ORGS

Orgenesis Inc. (ORGS) | Rumor.io

Orgenesis

ORGS

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio-0.01

Market capitalization827.4K

Earnings per share-11.4

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about ORGS?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% +0	0% 0

Aug 14

$ORGS stock up over +17% due to strategic partnership for a $10 million Longevity & Wellness Initiative, potentially creating new revenue streams.
Orgenesis Inc. ($ORGS) has announced a strategic partnership with Harley Street Healthcare Group to launch a state-of-the-art Longevity & Wellness Initiative globally.
$ORGS total assets have soared by 69% YoY, with the stock price looking good to test and break $1, with the next key level to test at 1.09 - 1.22.

Generated by AI

Sentiment

Of the messages about ORGS that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	0% -93.5
Bearish	—	—	—	100% +93.5

Bullish· Nov 7

Orgenesis Inc. ($ORGS) has received a $55 million investment from Metalmark Capital Partners, which could lead to a significant increase in its stock price.
The company's recent green candle on the 5-minute chart may indicate a turnaround, and its momentum is continuing with a price increase of 11.24% since its last mention.
Orgenesis Inc. is in an uptrend, with its RSI indicator exiting the oversold zone, making it a stock worth watching for further momentum.

Bearish· Nov 7

$ORGS price action suggests dilution, leading to a loss for some investors.
Despite a 2000% increase in volume, the stock is down 3%, indicating a disconnect between market sentiment and fundamentals.
The stock's recent performance may be attributed to a successful PR news release stunt by a firm to dump their shares, but this tactic may not be sustainable.

Generated by AI

Topics

Of the messages about ORGS that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	100%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	0%

Mar 17

Orgenesis Inc. has scheduled a conference call to discuss its fourth quarter 2022 business update.
The conference call is set to take place, with a specific date and time mentioned.
Orgenesis Inc. is highlighted as a trending stock on a specific date.

Generated by AI

Community

Of the messages about ORGS, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	0%	15.79%
Newcomers	100%	100%	100%	84.21%

Regulars· May 7

The company reported a four-fold revenue growth in Q1, with shares rising 11% and revenue increasing to $9.4 million, reflecting the initial success of its POCare platform.
Orgenesis' Q1 EPS was $0.01, up from $(0.39) YoY, and sales were $9.39M, up from $1.88M YoY, indicating a significant improvement in the company's financial performance.
The company's stock price has been gaining, with a 15.4% increase, and the Aroon indicator has dropped into a downtrend, but the company's overall performance and revenue growth are being closely watched by investors and analysts.

Newcomers· Mar 17

New investors are taking notice of ORGS, with one user asking how far the stock can go after reaching new highs.
Another user is discussing the stock's price and float, noting a short float of 1.6% and a price increase of 10.3%.
One user is setting a call entry level of $1.43 and a stop loss of $1.287, indicating a trading strategy for the stock.

Generated by AI

Also Discussed

Investors talking about ORGS also mention

#	Name	Attention
1	Nemaura Medical Inc.NMRD	0%new
2	Reed's, Inc.REED	0%new
3	TCON - TRACON Pharmaceuticals, Inc.	——
4	Par Technology Corp.PAR	0%0
5	Champions Oncology, Inc.CSBR	0%0
6	SBIG - SpringBig Holdings, Inc.	——
7	DPSI - Decisionpoint Systems, Inc.	——
8	Eastside Distilling Inc.EAST	0%new
9	LIPO - Lipella Pharmaceuticals Inc.	——
10	ONCS - OncoSec Medical Incorporated	——

Orgenesis Inc.

Location

Social

What share of all stock conversation is about ORGS?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% +0	0% 0

Aug 14

$ORGS stock up over +17% due to strategic partnership for a $10 million Longevity & Wellness Initiative, potentially creating new revenue streams.
Orgenesis Inc. ($ORGS) has announced a strategic partnership with Harley Street Healthcare Group to launch a state-of-the-art Longevity & Wellness Initiative globally.
$ORGS total assets have soared by 69% YoY, with the stock price looking good to test and break $1, with the next key level to test at 1.09 - 1.22.

Generated by AI

Sentiment

Of the messages about ORGS that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	0% -93.5
Bearish	—	—	—	100% +93.5

Bullish· Nov 7

Orgenesis Inc. ($ORGS) has received a $55 million investment from Metalmark Capital Partners, which could lead to a significant increase in its stock price.
The company's recent green candle on the 5-minute chart may indicate a turnaround, and its momentum is continuing with a price increase of 11.24% since its last mention.
Orgenesis Inc. is in an uptrend, with its RSI indicator exiting the oversold zone, making it a stock worth watching for further momentum.

Bearish· Nov 7

$ORGS price action suggests dilution, leading to a loss for some investors.
Despite a 2000% increase in volume, the stock is down 3%, indicating a disconnect between market sentiment and fundamentals.
The stock's recent performance may be attributed to a successful PR news release stunt by a firm to dump their shares, but this tactic may not be sustainable.

Generated by AI

Topics

Of the messages about ORGS that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	100%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	0%

Mar 17

Orgenesis Inc. has scheduled a conference call to discuss its fourth quarter 2022 business update.
The conference call is set to take place, with a specific date and time mentioned.
Orgenesis Inc. is highlighted as a trending stock on a specific date.

Generated by AI

Community

Of the messages about ORGS, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	0%	15.79%
Newcomers	100%	100%	100%	84.21%

Regulars· May 7

The company reported a four-fold revenue growth in Q1, with shares rising 11% and revenue increasing to $9.4 million, reflecting the initial success of its POCare platform.
Orgenesis' Q1 EPS was $0.01, up from $(0.39) YoY, and sales were $9.39M, up from $1.88M YoY, indicating a significant improvement in the company's financial performance.
The company's stock price has been gaining, with a 15.4% increase, and the Aroon indicator has dropped into a downtrend, but the company's overall performance and revenue growth are being closely watched by investors and analysts.

Newcomers· Mar 17

New investors are taking notice of ORGS, with one user asking how far the stock can go after reaching new highs.
Another user is discussing the stock's price and float, noting a short float of 1.6% and a price increase of 10.3%.
One user is setting a call entry level of $1.43 and a stop loss of $1.287, indicating a trading strategy for the stock.

Generated by AI

Orgenesis

Social

Aug 14

Sentiment

Bullish· Nov 7

Bearish· Nov 7

Topics

Mar 17

Community

Regulars· May 7

Newcomers· Mar 17

Also Discussed

Orgenesis Inc.

Company Information

Location

Also Discussed

Social

Aug 14

Sentiment

Bullish· Nov 7

Bearish· Nov 7

Topics

Mar 17

Community

Regulars· May 7

Newcomers· Mar 17